Literature DB >> 19520747

Renal vulnerability to drug toxicity.

Mark A Perazella1.   

Abstract

Drug-induced kidney disease occurs primarily in patients with underlying risk factors. A number of factors enhance the vulnerability of the kidney to the nephrotoxic effects of drugs and toxins. They are broadly categorized as patient-specific, kidney-related, and drug-related factors. One, two, or all three of the factor categories can act to promote various forms of renal injury. Importantly, all compartments of the kidney can be affected and result in one or more classic clinical renal syndromes. These include acute kidney injury, various tubulopathies, proteinuric renal disease, and chronic kidney disease. Recognizing risk factors that increase renal vulnerability to drug-induced kidney disease is the first step in reducing the renal complications of drugs and toxins.

Entities:  

Mesh:

Year:  2009        PMID: 19520747     DOI: 10.2215/CJN.02050309

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  80 in total

1.  Next-generation biomarkers for detecting kidney toxicity.

Authors:  Joseph V Bonventre; Vishal S Vaidya; Robert Schmouder; Peter Feig; Frank Dieterle
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

Review 2.  Pharmacology behind Common Drug Nephrotoxicities.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

3.  Spontaneous tumour lysis syndrome associated with contrast dye iohexol use in mantle cell lymphoma.

Authors:  Seongseok Yun; Nicole D Vincelette; Tuan Phan; Faiz Anwer
Journal:  BMJ Case Rep       Date:  2014-07-15

4.  A Case of Drug-Induced Proximal Tubular Dysfunction.

Authors:  Andrew M Hall; Robert J Unwin
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-10       Impact factor: 8.237

5.  Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.

Authors:  Kumiko Nishihara; Satohiro Masuda; Haruka Shinke; Aiko Ozawa; Takaharu Ichimura; Atsushi Yonezawa; Shunsaku Nakagawa; Ken-Ichi Inui; Joseph V Bonventre; Kazuo Matsubara
Journal:  Biochem Pharmacol       Date:  2013-01-02       Impact factor: 5.858

6.  Pemetrexed-Induced Nephrogenic Diabetes Insipidus.

Authors:  Enrica Fung; Shuchi Anand; Vivek Bhalla
Journal:  Am J Kidney Dis       Date:  2016-05-28       Impact factor: 8.860

7.  Role of heme oxygenase-1 in polymyxin B-induced nephrotoxicity in rats.

Authors:  Cassiane Dezoti Fonseca; Mirian Watanabe; Maria de Fátima Fernandes Vattimo
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

Review 8.  Tubulointerstitial nephritis: diagnosis, treatment, and monitoring.

Authors:  Emily Joyce; Paulina Glasner; Sarangarajan Ranganathan; Agnieszka Swiatecka-Urban
Journal:  Pediatr Nephrol       Date:  2016-05-07       Impact factor: 3.714

Review 9.  Drug-associated acute kidney injury: who's at risk?

Authors:  Emily L Joyce; Sandra L Kane-Gill; Dana Y Fuhrman; John A Kellum
Journal:  Pediatr Nephrol       Date:  2016-06-23       Impact factor: 3.714

10.  The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.

Authors:  Marion Pierson-Marchandise; Valérie Gras; Julien Moragny; Joelle Micallef; Louise Gaboriau; Sylvie Picard; Gabriel Choukroun; Kamel Masmoudi; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2017-03-14       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.